Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry.

Kreuter M, Swigris J, Pittrow D, Geier S, Klotsche J, Prasse A, Wirtz H, Koschel D, Andreas S, Claussen M, Grohé C, Wilkens H, Hagmeyer L, Skowasch D, Meyer JF, Kirschner J, Gläser S, Kahn N, Welte T, Neurohr C, Schwaiblmair M, Held M, Bahmer T, Oqueka T, Frankenberger M, Behr J.

Respir Res. 2019 Mar 15;20(1):59. doi: 10.1186/s12931-019-1020-3.

2.

Patients' perceptions and patient-reported outcomes in progressive-fibrosing interstitial lung diseases.

Swigris JJ, Brown KK, Abdulqawi R, Buch K, Dilling DF, Koschel D, Thavarajah K, Tomic R, Inoue Y.

Eur Respir Rev. 2018 Dec 21;27(150). pii: 180075. doi: 10.1183/16000617.0075-2018. Print 2018 Dec 31. Review.

3.

Long-term safety of pirfenidone: results of the prospective, observational PASSPORT study.

Cottin V, Koschel D, Günther A, Albera C, Azuma A, Sköld CM, Tomassetti S, Hormel P, Stauffer JL, Strombom I, Kirchgaessler KU, Maher TM.

ERJ Open Res. 2018 Oct 19;4(4). pii: 00084-2018. doi: 10.1183/23120541.00084-2018. eCollection 2018 Oct.

4.

Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer.

Kron A, Alidousty C, Scheffler M, Merkelbach-Bruse S, Seidel D, Riedel R, Ihle MA, Michels S, Nogova L, Fassunke J, Heydt C, Kron F, Ueckeroth F, Serke M, Krüger S, Grohe C, Koschel D, Benedikter J, Kaminsky B, Schaaf B, Braess J, Sebastian M, Kambartel KO, Thomas R, Zander T, Schultheis AM, Büttner R, Wolf J.

Ann Oncol. 2018 Oct 1;29(10):2068-2075. doi: 10.1093/annonc/mdy333.

5.

[DGP Interstitial Lung Disease Patient Questionnaire].

Kreuter M, Ochmann U, Koschel D, Behr J, Bonella F, Claussen M, Costabel U, Jungmann S, Kolb M, Nowak D, Petermann F, Pfeiffer M, Polke M, Prasse A, Schreiber J, Wälscher J, Wirtz H, Kirsten D.

Pneumologie. 2018 Jun;72(6):446-457. doi: 10.1055/s-0044-100207. Epub 2018 Feb 21. German.

PMID:
29466814
6.

German Guideline for Idiopathic Pulmonary Fibrosis - Update on Pharmacological Therapies 2017.

Behr J, Günther A, Bonella F, Geißler K, Koschel D, Kreuter M, Prasse A, Schönfeld N, Sitter H, Müller-Quernheim J, Costabel U.

Pneumologie. 2018 Feb;72(2):155-168. doi: 10.1055/s-0043-123035. Epub 2018 Jan 16.

7.

[Expert Knowledge and Supporting Advice for the Clinical Use of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis].

Behr J, Günther A, Kreuter M, Koschel D, Prasse A, Pfeifer M, Costabel U.

Pneumologie. 2017 Sep;71(9):567-579. doi: 10.1055/s-0043-109856. Epub 2017 Aug 3. Review. German.

PMID:
28772332
8.

Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry.

Kreuter M, Swigris J, Pittrow D, Geier S, Klotsche J, Prasse A, Wirtz H, Koschel D, Andreas S, Claussen M, Grohé C, Wilkens H, Hagmeyer L, Skowasch D, Meyer JF, Kirschner J, Gläser S, Herth FJF, Welte T, Neurohr C, Schwaiblmair M, Held M, Bahmer T, Frankenberger M, Behr J.

Respir Res. 2017 Jul 14;18(1):139. doi: 10.1186/s12931-017-0621-y.

9.

[German Guideline for Idiopathic Pulmonary Fibrosis - Update on Pharmacological Therapies 2017].

Behr J, Günther A, Bonella F, Geißler K, Koschel D, Kreuter M, Prasse A, Schönfeld N, Sitter H, Müller-Quernheim J, Costabel U.

Pneumologie. 2017 Jul;71(7):474. doi: 10.1055/s-0043-115504. Epub 2017 Jul 5. German. No abstract available.

PMID:
28679139
10.

[German Guideline for Idiopathic Pulmonary Fibrosis - Update on Pharmacological Therapies 2017].

Behr J, Günther A, Bonella F, Geißler K, Koschel D, Kreuter M, Prasse A, Schönfeld N, Sitter H, Müller-Quernheim J, Costabel U.

Pneumologie. 2017 Jul;71(7):460-474. doi: 10.1055/s-0043-106160. Epub 2017 May 30. German. Erratum in: Pneumologie. 2017 Jul;71(7):474.

PMID:
28558396
11.

Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone.

Kreuter M, Spagnolo P, Wuyts W, Renzoni E, Koschel D, Bonella F, Maher TM, Kolb M, Weycker D, Kirchgässler KU, Costabel U.

Respiration. 2017;93(6):415-423. doi: 10.1159/000468546. Epub 2017 Apr 12.

12.

Olfaction and sinonasal symptoms in patients with CRSwNP and AERD and without AERD: a cross-sectional and longitudinal study.

Gudziol V, Michel M, Sonnefeld C, Koschel D, Hummel T.

Eur Arch Otorhinolaryngol. 2017 Mar;274(3):1487-1493. doi: 10.1007/s00405-016-4366-x. Epub 2016 Nov 9.

PMID:
27830335
13.

Anti-acid treatment in patients with IPF: interpret results from post-hoc, subgroup, and exploratory analyses with great caution - Authors' reply.

Kreuter M, Wuyts W, Renzoni E, Koschel D, Maher TM, Kolb M, Weycker D, Spagnolo P, Kirchgaessler KU, Herth FJF, Costabel U.

Lancet Respir Med. 2016 Sep;4(9):e48. doi: 10.1016/S2213-2600(16)30235-1. No abstract available.

PMID:
27599251
14.

Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial.

Behr J, Bendstrup E, Crestani B, Günther A, Olschewski H, Sköld CM, Wells A, Wuyts W, Koschel D, Kreuter M, Wallaert B, Lin CY, Beck J, Albera C.

Lancet Respir Med. 2016 Jun;4(6):445-53. doi: 10.1016/S2213-2600(16)30044-3. Epub 2016 May 5.

PMID:
27161257
15.

Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis.

Kreuter M, Wuyts W, Renzoni E, Koschel D, Maher TM, Kolb M, Weycker D, Spagnolo P, Kirchgaessler KU, Herth FJ, Costabel U.

Lancet Respir Med. 2016 May;4(5):381-9. doi: 10.1016/S2213-2600(16)00067-9. Epub 2016 Mar 31.

16.

How to diagnose mould allergy? Comparison of skin prick tests with specific IgE results.

Kespohl S, Maryska S, Bünger J, Hagemeyer O, Jakob T, Joest M, Knecht R, Koschel D, Kotschy-Lang N, Merget R, Mülleneisen NK, Rabe U, Röseler S, Sander I, Stollewerk D, Straube H, Ulmer HM, van Kampen V, Walusiak-Skorupa J, Wiszniewska M, Wurpts G, Brüning T, Raulf M.

Clin Exp Allergy. 2016 Jul;46(7):981-91. doi: 10.1111/cea.12733. Epub 2016 May 3.

PMID:
27027397
17.

Occupational hypersensitivity pneumonitis: an EAACI position paper.

Quirce S, Vandenplas O, Campo P, Cruz MJ, de Blay F, Koschel D, Moscato G, Pala G, Raulf M, Sastre J, Siracusa A, Tarlo SM, Walusiak-Skorupa J, Cormier Y.

Allergy. 2016 Jun;71(6):765-79. doi: 10.1111/all.12866. Epub 2016 Mar 11. Review.

PMID:
26913451
18.

[Position Paper: Significance of the Forced Vital Capacity in Idiopathic Pulmonary Fibrosis].

Behr J, Bonella F, Bonnet R, Gläser S, Grohé C, Günther A, Koschel D, Kreuter M, Kirsten D, Krögel C, Markart P, Müller-Quernheim J, Neurohr C, Pfeifer M, Prasse A, Schönfeld N, Schreiber J, Wirtz H, Witt C, Costabel U.

Pneumologie. 2015 Aug;69(8):455-8. doi: 10.1055/s-0034-1392602. Epub 2015 Jul 30. German.

19.

Retrospective survival analysis of 237 consecutive patients with multiple pulmonary metastases from advanced renal cell carcinoma exclusively resected by a 1318-nm laser.

Baier B, Kern A, Kaderali L, Bis B, Koschel D, Rolle A.

Interact Cardiovasc Thorac Surg. 2015 Aug;21(2):211-7. doi: 10.1093/icvts/ivv120. Epub 2015 May 14.

PMID:
25977131
20.

Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry.

Behr J, Kreuter M, Hoeper MM, Wirtz H, Klotsche J, Koschel D, Andreas S, Claussen M, Grohé C, Wilkens H, Randerath W, Skowasch D, Meyer FJ, Kirschner J, Gläser S, Herth FJ, Welte T, Huber RM, Neurohr C, Schwaiblmair M, Kohlhäufl M, Höffken G, Held M, Koch A, Bahmer T, Pittrow D.

Eur Respir J. 2015 Jul;46(1):186-96. doi: 10.1183/09031936.00217614. Epub 2015 Apr 2.

21.

Symptom Burden and Health Related Quality of Life in Patients With Idiopathic Pulmonary Fibrosis in Clinical Practice: Insights-Ipf Registry.

Pittrow D, Klotsche J, Kreuter M, Hoeper MM, Wirtz H, Koschel D, Claussen M, Andreas S, Grohé C, Geier S, Koppe U, Behr J.

Value Health. 2014 Nov;17(7):A600. doi: 10.1016/j.jval.2014.08.2078. Epub 2014 Oct 26. No abstract available.

22.

Tolerated sting challenge in patients on Hymenoptera venom immunotherapy improves health-related quality of life.

Koschel DS, Schmies M, Weber CN, Höffken G, Balck F.

J Investig Allergol Clin Immunol. 2014;24(4):226-30.

23.

[Medical care for allergic disorders in Germany: a paradox].

Lommatzsch M, Koschel D, Welte T.

Pneumologie. 2013 Dec;67(12):659-61. doi: 10.1055/s-0033-1359000. Epub 2013 Dec 9. German.

24.

Tolerability to etoricoxib in patients with aspirin-exacerbated respiratory disease.

Koschel D, Weber CN, Höffken G.

J Investig Allergol Clin Immunol. 2013;23(4):275-80.

25.

Farmer's lung in a case after bullectomy.

Koschel D, Holfert J, Rolle A, Holotiuk O, Höffken G.

Int Arch Allergy Immunol. 2012;158(3):313-6. doi: 10.1159/000332960. Epub 2012 Mar 6.

PMID:
22398814
26.

Pulmonary hypertension in chronic hypersensitivity pneumonitis.

Koschel DS, Cardoso C, Wiedemann B, Höffken G, Halank M.

Lung. 2012 Jun;190(3):295-302. doi: 10.1007/s00408-011-9361-9. Epub 2012 Jan 19.

PMID:
22258419
27.

Pneumomediastinum as a primary manifestation of chronic hypersensitivity pneumonitis.

Koschel D, Handzhiev S, Cardoso C, Rolle A, Holotiuk O, Höffken G.

Med Sci Monit. 2011 Dec;17(12):CS152-5.

28.

Forceps biopsy and suction catheter for sampling in pulmonary nodules and infiltrates.

Peschke A, Wiedemann B, Höffken G, Koschel D.

Eur Respir J. 2012 Jun;39(6):1432-6. doi: 10.1183/09031936.00024111. Epub 2011 Oct 17.

29.

Antigen-specific IgG antibodies in feather duvet lung.

Koschel D, Lützkendorf L, Wiedemann B, Höffken G.

Eur J Clin Invest. 2010 Sep;40(9):797-802. doi: 10.1111/j.1365-2362.2010.02327.x. Epub 2010 Jun 28.

PMID:
20597960
30.

[Retrospective analysis of tuberculosis caused by Mycobacterium bovis 2004 - 2008].

Kolditz M, Koschel D, Philipp E, Höffken G.

Pneumologie. 2010 Nov;64(11):675-8. doi: 10.1055/s-0029-1244210. Epub 2010 Jun 11. German.

31.

Rheumatoid pneumoconiosis (Caplan's syndrome).

Schreiber J, Koschel D, Kekow J, Waldburg N, Goette A, Merget R.

Eur J Intern Med. 2010 Jun;21(3):168-72. doi: 10.1016/j.ejim.2010.02.004. Epub 2010 Mar 2. Review.

PMID:
20493416
32.

Combined vasomodulatory therapy for severe pulmonary hypertension in chronic hypersensitivity pneumonitis.

Koschel DS, Kolditz M, Höeffken G, Halank M.

Med Sci Monit. 2010 May;16(5):CS55-7.

PMID:
20424556
33.

Presenting features of feather duvet lung.

Koschel D, Wittstruck H, Renck T, Müller-Wening D, Höffken G.

Int Arch Allergy Immunol. 2010;152(3):264-70. doi: 10.1159/000283036. Epub 2010 Feb 12.

PMID:
20150744
34.

[Current concepts for the microbiological detection of airway pathogens].

Höffken G, Kolditz M, Halank M, Lück C, Koschel D.

Pneumologie. 2010 Mar;64(3):184-93. doi: 10.1055/s-0029-1215132. Epub 2009 Nov 16. German.

35.

Acute effects of NPPV in interstitial lung disease with chronic hypercapnic respiratory failure.

Koschel D, Handzhiev S, Wiedemann B, Höffken G.

Respir Med. 2010 Feb;104(2):291-5. doi: 10.1016/j.rmed.2009.09.017. Epub 2009 Oct 17.

36.

Hypersensitivity pneumonitis associated with the use of temozolomide.

Koschel D, Handzhiev S, Leucht V, Holotiuk O, Fisseler-Eckhoff A, Höffken G.

Eur Respir J. 2009 Apr;33(4):931-4. doi: 10.1183/09031936.00004808.

37.

Medical management of pulmonary actinomycosis: data from 49 consecutive cases.

Kolditz M, Bickhardt J, Matthiessen W, Holotiuk O, Höffken G, Koschel D.

J Antimicrob Chemother. 2009 Apr;63(4):839-41. doi: 10.1093/jac/dkp016. Epub 2009 Feb 13. No abstract available.

PMID:
19218569
38.

Asthmatic reaction induced by Etoricoxib in a patient with aspirin-sensitive asthma.

Koschel D, Cardoso C, Leucht V, Hoffken G.

Allergy. 2008 Aug;63(8):1093-4. doi: 10.1111/j.1398-9995.2008.01782.x. No abstract available.

PMID:
18691317
39.

[Extrinsic allergic alveolitis/hypersensitivity pneumonitis].

Koschel D.

Pneumologie. 2007 May;61(5):305-22. German. No abstract available.

PMID:
17523071
40.

[Guidelines for diagnosing extrinsic allergic alveolitis (hypersensitivity pneumonitis) (German Extrinsic Allergic Alveolitis Study Group)].

Sennekamp J, Müller-Wening D, Amthor M, Baur X, Bergmann KC, Costabel U, Kirsten D, Koschel D, Kroidl R, Liebetrau G, Nowak D, Schreiber J, Vogelmeier C; German Extrinsic Allergic Alveolitis Study Group.

Pneumologie. 2007 Jan;61(1):52-6. Review. German. No abstract available.

41.

[Swimming pool lung -- extrinsic allergic alveolitis or mycobacterial disease?].

Koschel D, Pietrzyk C, Sennekamp J, Müller-Wening D.

Pneumologie. 2006 May;60(5):285-9. German.

PMID:
16703482
42.

[Humidifier-associated disease in the general population].

Müller-Wening D, Koschel D, Stark W, Sennekamp HJ.

Dtsch Med Wochenschr. 2006 Mar 10;131(10):491-6. German.

PMID:
16511738
43.

Extrinsic allergic alveolitis caused by misting fountains.

Koschel D, Stark W, Karmann F, Sennekamp J, Müller-Wening D.

Respir Med. 2005 Aug;99(8):943-7.

44.

[Misting-fountain-alveolitis].

Koschel D, Sennekamp J, Schurz C, Müller-Wening D.

Pneumologie. 2004 Sep;58(9):666-9. German.

PMID:
15343489
45.

[Pulmonary Langerhans-cell histiocytosis].

Koschel D, Müller-Wening D.

Med Klin (Munich). 2003 Aug 15;98(8):461-3. German. No abstract available.

PMID:
12928813
46.

[Stroke unit in a medical clinic: one year results and perspectives].

Koschel D, Prassler R.

Dtsch Med Wochenschr. 2001 Jun 22;126(25-26):739-44. German.

PMID:
11455664

Supplemental Content

Loading ...
Support Center